Rankings
▼
Calendar
ANNX Q4 2021 Earnings — Annexon, Inc. Revenue & Financial Results | Market Cap Arena
ANNX
Annexon, Inc.
$713M
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$37M
Net Income
-$37M
EPS (Diluted)
$-0.97
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$28M
Free Cash Flow
-$29M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$287M
Total Liabilities
$55M
Stockholders' Equity
$232M
Cash & Equivalents
$75M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$37M
-$23M
-61.5%
Net Income
-$37M
-$23M
-61.1%
← FY 2021
All Quarters
Q1 2022 →